ShockWave Medical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023
Net Income	-14.1	-8.93
Depreciation & Amortization	0.13	0.07
Stock-Based Compensation	2.16	1.75
Other Operating Activities	0.09	0.05
Change in Accounts Payable	0.58	0.31
Change in Other Net Operating Assets	3.92	-1.25
Operating Cash Flow	-7.24	-8
Capital Expenditures	-0	-0.04
Investment in Securities	-	-2.6
Investing Cash Flow	1.53	-2.64
Issuance of Common Stock	-	0
Repurchase of Common Stock	-	-0
Financing Cash Flow	1.81	13.12
Foreign Exchange Rate Adjustments	-0.08	0.04
Miscellaneous Cash Flow Adjustments	-0	-0
Net Cash Flow	-3.97	2.53
Free Cash Flow	-7.24	-8.04
Free Cash Flow Margin	-1066.46%	-3852.31%
Free Cash Flow Per Share	-76.58	-105.04

Source: S&P Global Market Intelligence. Standard template. Financial Sources.